Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
The current Eli Lilly(LLY) stock price is $911.47, with a market capitalization of 856.56B. The stock trades at a price-to-earnings (P/E) ratio of 39.51 and offers a dividend yield of 68.7%.
As of 2026-03-21, Eli Lilly(LLY) stock has fluctuated between $899.52 and $925.38. The current price stands at $911.47, placing the stock +1.3% above today's low and -1.5% off the high.
Eli Lilly(LLY) shares are trading with a volume of 4.82M, against a daily average of 2.88M.
During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.
LLY News
Key Points Eli Lilly is well-positioned to maintain its lead in the anti-obesity market. The company's newer products in this niche will help expand its reach...
Eli Lilly & Co ( (LLY) ) has fallen by -8.33%. Read on to learn why. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools fo...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly and Company (LLY) is running a late-stage study of retatrutide, a we...
Analyst ratings
80%
of 35 ratingsMore LLY News
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The study A Study to Assess the Use of the Somfit, an Ambulatory Electroenceph...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The study A Randomized, Investigator- and Participant-blinded, Multiple-ascend...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly and Co. (LLY) is preparing a new Phase 2 trial called EMERALD-3 for...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The study, titled “An Adaptive Two-Stage Bioequivalence Study of Subcutaneous...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly and Company (LLY) is launching a Phase 2 trial titled “A Phase 2, Mu...
RBC Capital says that while the overall tolerability and A1C reductions for Eli Lilly’s (LLY) retatrutide in the TRANSCEND-T2D-1 study were worse compared to Mo...
Deutsche Bank says Eli Lilly’s (LLY) retatrutide showed absolute estimated weight loss of 15% or 13% placebo-adjusted, which compares favorably to Mounjaro’s SU...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.